Login / Signup

Reply to: Can circulating CD34+ cells count be used for the prognosis of myelofibrosis? Probably yes, at least in patients treated with ruxolitinib.

Alessandra IurloNicole GalliCristina BucelliSilvia ArtusoDario ConsonniDaniele Cattaneo
Published in: British journal of haematology (2023)
Keyphrases
  • induced apoptosis
  • cell cycle arrest
  • cell death
  • signaling pathway
  • peripheral blood
  • cell proliferation